GWPH News and Press, GW Pharmaceuticals Plc From 11/04/20

Why These Marijuana Stocks Are Still On Top As November starts off strong, many investors are still working to find marijuana stocks to watch . Of course, we have obvious choices like Green Thumb Industries Inc. ( GTBIF Stock Report ) and GW Pharmaceuticals Inc. ( GWPH Stock R...

Image source: The Motley Fool. GW Pharmaceuticals PLC (NASDAQ: GWPH) Q3 2020 Earnings Call Nov 3, 2020 , 8:30 a.m. ET Operator Continue reading For further details see: GW Pharmaceuticals PLC (GWPH) Q3 2020 Earnings Call Transcript

Delta, Kelowna, BC - November 3, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus ins...

GW Pharmaceuticals plc (GWPH) Q3 2020 Results Earnings Conference Call November 3, 2020, 8:30 AM ET Company Participants Stephen Schultz - Vice President, Investor Relations Justin Gover - Chief Executive Officer Darren Cline - U.S. Chief Commercial Officer Chris Tovey - Chief Operating Offic...

You might think that GW Pharmaceuticals (NASDAQ: GWPH) has had a lot of bad news in 2020 if you looked only at its stock performance. That isn't the case, though. The company has won key regulatory approvals and delivered solid revenue growth -- at least so far this year. GW's g...

GW Pharmaceuticals (NASDAQ: GWPH) announced today that it is starting up its phase 3 trial for nabiximols, an oral spray for patients who have spasticity associated with multiple sclerosis (MS). Nabiximols is a botanical medicine derived from cannabis plants. The drug, sold as Sativ...

Gainers: Alaska Communications Systems (ALSK) +58%.Beasley Broadcast (BBGI) +39%.JAKKS Pacific (JAKK) +29%.BioLineRx (BLRX) +27%.Gannett Co (GCI) +25%.Inspire Medical Systems (INSP) +24%.GW Pharmaceuticals (GWPH) +20%.Collectors Universe (CLCT) +20%.Telenav (TNAV) +20%.Aptevo Therap...

Gainers: Inspire Medical Systems (INSP) +24%, GW Pharmaceuticals (GWPH) +15%, Aptevo Therapeutics (APVO) +14%, Galera Therapeutics (GRTX) +11%, DBV Technologies (DBVT) +10%.Losers: Esperion Therapeutics (ESPR) -15%, Aurinia Pharmaceuticals (AUPH)&#...

GW Pharmaceuticals (GWPH) Q3 results:Revenue: $137.05M (+50.7% Y/Y) vs consensus of $125.97M; Epidiolex U.S. sales: $121.6M.Net loss: ($12.2M) (-11.6%); loss/share: ($0.03) (-25.0%) vs consensus of ($0.06).Cash flow ops: ($33.31M) (-69.0%).Epidiolex for seizures associated with ...

GW Pharmaceuticals (GWPH) has initiated U.S. Phase 3 trial for nabiximols in multiple sclerosis ((MS))-associated spasticity. The 446-subject study will evaluate the safety and efficacy of nabiximols for spasm frequency over a 12-week period. The first patient is now screened and in baseline ...